Product image of Visipaque (Iodixanol) supplied by GNH India

Visipaque

Active Ingredient:
Iodixanol
Origin:
EU

Visipaque (Iodixanol)

Visipaque (Iodixanol) is a non-ionic, iso-osmolar contrast agent used in medical imaging procedures. It enhances visibility of blood vessels and organs during X-ray, CT, and other imaging scans. Designed for safety and clarity, it supports accurate diagnostic outcomes. Suitable for intraarterial, intravenous, and intrathecal use.

Manufacturer / TM Owner

Ge Healthcare As

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Visipaque (Iodixanol) is commonly used as a contrast agent in various imaging techniques to improve the visibility of blood vessels, organs, and tissues. It is particularly useful in procedures such as CT scans, angiograms, and myelograms. This contrast agent helps radiologists and healthcare providers obtain clearer images for accurate diagnosis. It is also used in intrathecal imaging to visualize the spinal canal and surrounding structures.

Side Effects

  • Visipaque (Iodixanol) works by temporarily altering the way X-rays or other imaging techniques interact with the body, making certain areas appear more distinct. Patients may experience a warm sensation or mild discomfort during administration, which is generally temporary. Some individuals report a metallic taste in the mouth shortly after injection. These effects are typically short-lived and resolve without intervention.

Precautions & Warnings

  • Visipaque (Iodixanol) should be used with caution in patients with known allergies to iodinated contrast agents or severe kidney impairment. Adequate hydration before and after administration is recommended to support kidney function. Healthcare providers should assess the patient’s medical history, including thyroid disorders and diabetes, prior to use. It is important to monitor for signs of adverse reactions during and after the procedure.

Avoid Interactions

  • Visipaque (Iodixanol) may interact with medications that affect kidney function, such as certain diuretics or nonsteroidal anti-inflammatory drugs (NSAIDs). Patients taking metformin should temporarily discontinue its use before and after contrast administration due to the risk of lactic acidosis. Alcohol and other substances that may impair kidney function should be avoided around the time of imaging. Always inform your healthcare provider about all medications and supplements being taken.

Frequently Asked Questions

Visipaque is used as a contrast agent to enhance the visibility of blood vessels, organs, and tissues during imaging procedures like CT scans and angiograms.

Visipaque is administered via injection, typically intravenously, intraarterially, or intrathecally, depending on the imaging procedure.

Common side effects may include a warm sensation, mild discomfort, or a metallic taste in the mouth, which are usually temporary.

Visipaque should be used with caution in patients with kidney impairment, and adequate hydration is recommended before and after administration.

Visipaque may interact with medications affecting kidney function, such as metformin or diuretics, so inform your healthcare provider about all medications you are taking.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Iodixanol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT